The research team projects that the Biosimilars/Follow-on-Biologics market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Novartis
Merck Group
LG Life Sciences
Synthon Pharmaceuticals
Hospira
Teva Pharmaceutical Industries
Genentech (Roche Group)
Biocon
Celltrion
Biogen idec, Inc.
By Type
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
By Application
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biosimilars/Follow-on-Biologics 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biosimilars/Follow-on-Biologics Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biosimilars/Follow-on-Biologics Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biosimilars/Follow-on-Biologics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Biosimilars/Follow-on-Biologics Revenue
1.5 Market Analysis by Type
1.5.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.5.2 Human growth hormone
1.5.3 Erythropoietin
1.5.4 Monoclonal antibodies
1.5.5 Insulin
1.5.6 Interferon
1.5.7 Granulocyte-Colony Stimulating Factor
1.5.8 Peptide
1.5.9 Others
1.6 Market by Application
1.6.1 Global Biosimilars/Follow-on-Biologics Market Share by Application: 2021-2026
1.6.2 Blood disorders
1.6.3 Oncology diseases
1.6.4 Chronic and autoimmune diseases
1.6.5 Growth hormone deficiencies
1.6.6 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Biosimilars/Follow-on-Biologics Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter's Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Biosimilars/Follow-on-Biologics Market Players Profiles
3.1 Novartis
3.1.1 Novartis Company Profile
3.1.2 Novartis Biosimilars/Follow-on-Biologics Product Specification
3.1.3 Novartis Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.2 Merck Group
3.2.1 Merck Group Company Profile
3.2.2 Merck Group Biosimilars/Follow-on-Biologics Product Specification
3.2.3 Merck Group Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.3 LG Life Sciences
3.3.1 LG Life Sciences Company Profile
3.3.2 LG Life Sciences Biosimilars/Follow-on-Biologics Product Specification
3.3.3 LG Life Sciences Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 Synthon Pharmaceuticals
3.4.1 Synthon Pharmaceuticals Company Profile
3.4.2 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Specification
3.4.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Hospira
3.5.1 Hospira Company Profile
3.5.2 Hospira Biosimilars/Follow-on-Biologics Product Specification
3.5.3 Hospira Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 Teva Pharmaceutical Industries
3.6.1 Teva Pharmaceutical Industries Company Profile
3.6.2 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Specification
3.6.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Genentech (Roche Group)
3.7.1 Genentech (Roche Group) Company Profile
3.7.2 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Specification
3.7.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Biocon
3.8.1 Biocon Company Profile
3.8.2 Biocon Biosimilars/Follow-on-Biologics Product Specification
3.8.3 Biocon Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Celltrion
3.9.1 Celltrion Company Profile
3.9.2 Celltrion Biosimilars/Follow-on-Biologics Product Specification
3.9.3 Celltrion Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Biogen idec, Inc.
3.10.1 Biogen idec, Inc. Company Profile
3.10.2 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Specification
3.10.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Biosimilars/Follow-on-Biologics Market Competition by Market Players
4.1 Global Biosimilars/Follow-on-Biologics Production Capacity Market Share by Market Players (2015-2020)
4.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Market Players (2015-2020)
4.3 Global Biosimilars/Follow-on-Biologics Average Price by Market Players (2015-2020)
5 Global Biosimilars/Follow-on-Biologics Production by Regions (2015-2020)
5.1 North America
5.1.1 North America Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.1.2 Biosimilars/Follow-on-Biologics Key Players in North America (2015-2020)
5.1.3 North America Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.1.4 North America Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.2 East Asia
5.2.1 East Asia Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.2.2 Biosimilars/Follow-on-Biologics Key Players in East Asia (2015-2020)
5.2.3 East Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.2.4 East Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.3 Europe
5.3.1 Europe Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.3.2 Biosimilars/Follow-on-Biologics Key Players in Europe (2015-2020)
5.3.3 Europe Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.3.4 Europe Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.4 South Asia
5.4.1 South Asia Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.4.2 Biosimilars/Follow-on-Biologics Key Players in South Asia (2015-2020)
5.4.3 South Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.4.4 South Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.5 Southeast Asia
5.5.1 Southeast Asia Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.5.2 Biosimilars/Follow-on-Biologics Key Players in Southeast Asia (2015-2020)
5.5.3 Southeast Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.5.4 Southeast Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.6 Middle East
5.6.1 Middle East Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.6.2 Biosimilars/Follow-on-Biologics Key Players in Middle East (2015-2020)
5.6.3 Middle East Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.6.4 Middle East Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.7 Africa
5.7.1 Africa Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.7.2 Biosimilars/Follow-on-Biologics Key Players in Africa (2015-2020)
5.7.3 Africa Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.7.4 Africa Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.8 Oceania
5.8.1 Oceania Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.8.2 Biosimilars/Follow-on-Biologics Key Players in Oceania (2015-2020)
5.8.3 Oceania Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.8.4 Oceania Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.9 South America
5.9.1 South America Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.9.2 Biosimilars/Follow-on-Biologics Key Players in South America (2015-2020)
5.9.3 South America Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.9.4 South America Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5.10 Rest of the World
5.10.1 Rest of the World Biosimilars/Follow-on-Biologics Market Size (2015-2020)
5.10.2 Biosimilars/Follow-on-Biologics Key Players in Rest of the World (2015-2020)
5.10.3 Rest of the World Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
5.10.4 Rest of the World Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
6 Global Biosimilars/Follow-on-Biologics Consumption by Region (2015-2020)
6.1 North America
6.1.1 North America Biosimilars/Follow-on-Biologics Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Biosimilars/Follow-on-Biologics Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Biosimilars/Follow-on-Biologics Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Biosimilars/Follow-on-Biologics Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Biosimilars/Follow-on-Biologics Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Biosimilars/Follow-on-Biologics Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Biosimilars/Follow-on-Biologics Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Biosimilars/Follow-on-Biologics Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Biosimilars/Follow-on-Biologics Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Biosimilars/Follow-on-Biologics Consumption by Countries
7 Global Biosimilars/Follow-on-Biologics Production Forecast by Regions (2021-2026)
7.1 Global Forecasted Production of Biosimilars/Follow-on-Biologics (2021-2026)
7.2 Global Forecasted Revenue of Biosimilars/Follow-on-Biologics (2021-2026)
7.3 Global Forecasted Price of Biosimilars/Follow-on-Biologics (2021-2026)
7.4 Global Forecasted Production of Biosimilars/Follow-on-Biologics by Region (2021-2026)
7.4.1 North America Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.2 East Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.3 Europe Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.4 South Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.5 Southeast Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.6 Middle East Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.7 Africa Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.8 Oceania Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.9 South America Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.4.10 Rest of the World Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
7.5 Forecast by Type and by Application (2021-2026)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
7.5.2 Global Forecasted Consumption of Biosimilars/Follow-on-Biologics by Application (2021-2026)
8 Global Biosimilars/Follow-on-Biologics Consumption Forecast by Regions (2021-2026)
8.1 North America Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
8.2 East Asia Market Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
8.3 Europe Market Forecasted Consumption of Biosimilars/Follow-on-Biologics by Countriy
8.4 South Asia Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
8.5 Southeast Asia Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
8.6 Middle East Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
8.7 Africa Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
8.8 Oceania Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
8.9 South America Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
8.10 Rest of the world Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
9 Global Biosimilars/Follow-on-Biologics Sales by Type (2015-2026)
9.1 Global Biosimilars/Follow-on-Biologics Historic Market Size by Type (2015-2020)
9.2 Global Biosimilars/Follow-on-Biologics Forecasted Market Size by Type (2021-2026)
10 Global Biosimilars/Follow-on-Biologics Consumption by Application (2015-2026)
10.1 Global Biosimilars/Follow-on-Biologics Historic Market Size by Application (2015-2020)
10.2 Global Biosimilars/Follow-on-Biologics Forecasted Market Size by Application (2021-2026)
11 Global Biosimilars/Follow-on-Biologics Manufacturing Cost Analysis
11.1 Biosimilars/Follow-on-Biologics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
12 Global Biosimilars/Follow-on-Biologics Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Biosimilars/Follow-on-Biologics Distributors List
12.3 Biosimilars/Follow-on-Biologics Customers
12.4 Biosimilars/Follow-on-Biologics Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer
The Biologics Outsourcing Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Sterile Biologics Filling Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...
Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...
North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, ...
Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing cl...